SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-090905
Filing Date
2024-08-05
Accepted
2024-08-05 16:50:11
Documents
57
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arct-20240630.htm   iXBRL 10-Q 1357340
2 EX-10.35 arct-ex10_35.htm EX-10.35 39040
3 EX-31.1 arct-ex31_1.htm EX-31.1 15381
4 EX-31.2 arct-ex31_2.htm EX-31.2 15339
5 EX-32.1 arct-ex32_1.htm EX-32.1 8282
6 EX-32.2 arct-ex32_2.htm EX-32.2 8251
7 GRAPHIC img267163886_0.jpg GRAPHIC 21592
8 GRAPHIC img267163886_1.jpg GRAPHIC 90057
9 GRAPHIC img267163886_2.jpg GRAPHIC 48082
  Complete submission text file 0000950170-24-090905.txt   5918354

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT arct-20240630.xsd EX-101.SCH 976931
59 EXTRACTED XBRL INSTANCE DOCUMENT arct-20240630_htm.xml XML 693886
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38942 | Film No.: 241175638
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)